✦ LIBER ✦

Perioperative complications in inflammatory bowel disease

✍ Scribed by David Beddy; Eric J. Dozois; John H. Pemberton

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 209 KB
Volume: 17
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.21504

No coin nor oath required. For personal study only.

✦ Synopsis

Almost 50% of patients with inflammatory bowel disease (IBD) will undergo surgery for their disease at some stage of its clinical course. Complications seen following surgery may occur early or late in the postoperative period. Patient factors, including active inflammatory disease, malnutrition, and use of immunosuppressant medications, make these patients a challenging surgical group and at increased risk for surgical complications. The purpose of this review is to characterize the complications that are commonly seen following surgery in patients with IBD and to discuss the surgical and patient factors that may influence their development.

📜 SIMILAR VOLUMES

Renal manifestations and complications o

Renal manifestations and complications of inflammatory bowel disease

✍ Konstantinos Oikonomou; Andreas Kapsoritakis; Theodoros Eleftheriadis; Ioannis S 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

Renal manifestations and complications are not rare in patients with inflammatory bowel disease (IBD) and may present as nephrolithiasis, amyloidosis, tubulointerstitial nephritis, and glomerulonephritis. Symptoms of renal impairment are not always specific and since the underlying bowel disease is

Lymphoma in inflammatory bowel disease

✍ Adrian J. Greenstein; Gerard E. Mullin; James A. Strauchen; Tomas Heimann; Henry 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 481 KB 👁 1 views

MicroRNAs in inflammatory bowel disease

✍ Joel R. Pekow; John H. Kwon 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

MicroRNAs (miRNAs) are small, noncoding RNAs that regulate gene and protein expression. miRNAs are critical to a normal immune response and have altered expression in multiple immune-mediated disorders. This emerging role of miRNAs in the pathogenesis of multiple disease states has led to investigat

Antimicrobial cover in inflammatory bowe

Antimicrobial cover in inflammatory bowel disease

✍ R. V. Fiddian; M. R. B. Keighley 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

Pyoderma gangrenosum in inflammatory bow

Pyoderma gangrenosum in inflammatory bowel disease

✍ M. D. Levitt; J. K. Ritchie; J. E. Lennard-Jones; Mr. R. K. S. Phillips 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB 👁 2 views

Mucocutaneous manifestations in inflamma

Mucocutaneous manifestations in inflammatory bowel disease

✍ İlhami Yüksel; Ömer Başar; Hilmi Ataseven; İbrahim Ertuğrul; Mehmet Arhan; Mehme 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

## Background: The aim of this study was to evaluate the prevalence and features of the major cutaneous manifestations (erythema nodosum [en] and pyoderma gangrenosum [pg]) and to determine the associations between cutaneous manifestations and other extraintestinal manifestations in patients with i